Analysis of the gene expressions of 329 melanoma patients from TCGA database, yielded three-class GESs (“immune”, “keratin”, and “MITF-low”) with the poorest survival of patients with the “keratin” signature [18]. This evidence concerns the gene MITF and melanoma.